Search Results - "Szucs, T."

Direct Measurement of the C 13 ( α , n ) O 16 Cross Section into the s -Process Gamow Peak by Ciani, G. F., Csedreki, L., Rapagnani, D., Aliotta, M., Balibrea-Correa, J., Barile, F., Bemmerer, D., Best, A., Boeltzig, A., Broggini, C., Bruno, C. G., Caciolli, A., Cavanna, F., Chillery, T., Colombetti, P., Corvisiero, P., Cristallo, S., Davinson, T., Depalo, R., Di Leva, A., Elekes, Z., Ferraro, F., Fiore, E., Formicola, A., Fülöp, Zs, Gervino, G., Guglielmetti, A., Gustavino, C., Gyürky, Gy, Imbriani, G., Junker, M., Lugaro, M., Marigo, P., Masha, E., Menegazzo, R., Mossa, V., Pantaleo, F. R., Paticchio, V., Perrino, R., Piatti, D., Prati, P., Schiavulli, L., Stöckel, K., Straniero, O., Szücs, T., Takács, M. P., Terrasi, F., Vescovi, D., Zavatarelli, S.

Get full text

Direct Capture Cross Section and the E p = 71 and 105 keV Resonances in the Ne 22 ( p , γ ) Na 23 Reaction by Ferraro, F., Takács, M. P., Piatti, D., Cavanna, F., Depalo, R., Aliotta, M., Bemmerer, D., Best, A., Boeltzig, A., Broggini, C., Bruno, C. G., Caciolli, A., Chillery, T., Ciani, G. F., Corvisiero, P., Davinson, T., D’Erasmo, G., Di Leva, A., Elekes, Z., Fiore, E. M., Formicola, A., Fülöp, Zs, Gervino, G., Guglielmetti, A., Gustavino, C., Gyürky, Gy, Imbriani, G., Junker, M., Karakas, A., Kochanek, I., Lugaro, M., Marigo, P., Menegazzo, R., Mossa, V., Pantaleo, F. R., Paticchio, V., Perrino, R., Prati, P., Schiavulli, L., Stöckel, K., Straniero, O., Szücs, T., Trezzi, D., Zavatarelli, S.

Get full text

Pharmacogenetic information in Swiss drug labels – a systematic analysis by Jeiziner, C., Suter, K., Wernli, U., Barbarino, J. M., Gong, L., Whirl-Carrillo, M., Klein, T. E., Szucs, T. D., Hersberger, K. E., Meyer zu Schwabedissen, H. E.

“…Implementation of pharmacogenetics (PGx) and individualization of drug therapy is supposed to obviate adverse drug reactions or therapy failure. Health care…”
Get full text

Personalized cancer medicine and the future of pathology by Moch, H., Blank, P. R., Dietel, M., Elmberger, G., Kerr, K. M., Palacios, J., Penault-Llorca, F., Rossi, G., Szucs, T. D.

“…In February 2011, a group of pathologists from different departments in Europe met in Zurich, Switzerland, to discuss opportunities and challenges for…”
Get full text

Disparities in influenza vaccination coverage rates by target group in five European countries: Trends over seven consecutive seasons by Blank, P. R, Schwenkglenks, M, Szucs, T. D

“…Background: The primary objective of this study was to measure influenza vaccination coverage rates in the general population, including children, and in…”
Get full text

Geographic disparities in access to cancer care: do patients in outlying areas talk about their access problems to their general practitioners and medical oncologists and how does that impact on the choice of chemotherapy? by Groux, P., Szucs, T.

“…Geographic disparities in access to cancer care have been reported for several countries. The distance between the place of residence and the cancer care…”
Get full text

Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial by Dedes, KJ, Szucs, TD, Imesch, P, Fedier, A, Fehr, MK, Fink, D

“…Background: Routine adjuvant administration of trastuzumab (T) has been implemented in most centers, but its economic impact has not yet been well examined…”
Get full text

Determination of luminosity for in-ring reactions: A new approach for the low-energy domain by Xing, Y.M., Glorius, J., Varga, L., Bott, L., Brandau, C., Brückner, B., Chen, R.J., Chen, X., Dababneh, S., Davinson, T., Erbacher, P., Fiebiger, S., Gaßner, T., Göbel, K., Groothuis, M., Gumberidze, A., Gyürky, G., Heil, M., Hess, R., Hensch, R., Hillmann, P., Hillenbrand, P.-M., Hinrichs, O., Jurado, B., Kausch, T., Khodaparast, A., Kisselbach, T., Klapper, N., Kozhuharov, C., Kurtulgil, D., Lane, G., Langer, C., Lederer-Woods, C., Lestinsky, M., Litvinov, S., Litvinov, Yu.A., Löher, B., Petridis, N., Popp, U., Reed, M., Reifarth, R., Sanjari, M.S., Simon, H., Slavkovská, Z., Spillmann, U., Steck, M., Stöhlker, T., Stumm, J., Szücs, T., Nguyen, T.T., Zadeh, A. Taremi, Thomas, B., Torilov, S.Yu, Törnqvist, H., Trageser, C., Trotsenko, S., Volknandt, M., Wang, M., Weigand, M., Wolf, C., Woods, P.J., Zhang, Y.H., Zhou, X.H.

“…Luminosity is a measure of the colliding frequency between beam and target and it is a crucial parameter for the measurement of absolute values, such as…”
Get full text

Trastuzumab beyond progression: a cost-utility analysis by Matter-Walstra, K.W., Dedes, K.J., Schwenkglenks, M., Brauchli, P., Szucs, T.D., Pestalozzi, B.C.

“…The continuation of trastuzumab beyond progression in combination with capecitabine as secondary chemotherapy for HER2-positive metastatic breast cancer (MBC)…”
Get full text

Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05 by Müller, D, Szucs, T D

“…Influenza continues to be a considerable health problem in Europe. Vaccination is the only preventive measure, reducing mortality and morbidity of influenza in…”
Get full text

Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel by Vulsteke, C., Pfeil, A. M., Schwenkglenks, M., Pettengell, R., Szucs, T. D., Lambrechts, D., Peeters, M., van Dam, P., Dieudonné, A. S., Hatse, S., Neven, P., Paridaens, R., Wildiers, H.

“…To assess the impact of patient-related factors, including genetic variability in genes involved in the metabolism of chemotherapeutic agents, on breast…”
Get full text

Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD) by Pfeil, A. M., Imfeld, P., Pettengell, R., Jick, S. S., Szucs, T. D., Meier, Christoph R., Schwenkglenks, M.

“…Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in European adults. We aimed to evaluate time trends in CLL incidence and medical resource…”
Get full text

Reducing the Burden of Influenza-Associated Complications with Antiviral Therapy by Ruf, B. R, Szucs, T

“…Introduction: Influenza imposes an annual burden on individuals, society, and healthcare systems. This burden is increased by the development of complications…”
Get full text

Cost-effectiveness of antihypertensive treatment in patients 80 years of age or older in Switzerland: an analysis of the HYVET study from a Swiss perspective by Szucs, T D, Waeber, B, Tomonaga, Y

“…This analysis shows the economic benefit of antihypertensive treatment in patients 80 years of age or older from the perspective of the Swiss healthcare…”
Get full text

S1 Modern cancer drugs – will they be affordable in the future? by Szucs, T

Get full text

Ultra-sensitive γ-ray spectroscopy set-up for investigating primordial lithium problem by Gervino, G., Gustavino, C., Trezzi, D., Aliotta, M., Anders, M., Boeltzig, A., Bemmerer, D., Best, A., Broggini, C., Bruno, C., Caciolli, A., Cavanna, F., Corvisiero, P., Davinson, T., Depalo, R., DiLeva, A., Elekes, Z., Ferraro, F., Formicola, A., Fülöp, Zs, Guglielmetti, A., Gyürky, Gy, Imbriani, G., Junker, M., Menegazzo, R., Prati, P., Scott, D.A., Straniero, O., Szücs, T.

“…To precisely determine BBN 6Li production, the cross-section of the nuclear reaction 2H(α, γ)6Li must be directly measured within the astrophysical energy…”
Get full text

Precise resonance parameter measurement in the 12C(p,γ)13N astrophysically important reaction by Csedreki, L., Gyürky, Gy, Szücs, T.

“…Precise knowledge of the 12C(p,γ)13N reaction cross section is crucial to understand the evolution of various types of red giant stars and to explain their…”
Get full text

Modelling in economic evaluation: an unavoidable fact of life by Buxton, M J, Drummond, M F, Van Hout, B A, Prince, R L, Sheldon, T A, Szucs, T, Vray, M

“…The role of modelling in economic evaluation is explored by discussing, with examples, the uses of models. The expanded use of pragmatic clinical trials as an…”
Get full text

Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia by Szucs, T D, Blank, P R, Schwenkglenks, M, Aapro, M

“…Intravenous (i.v.) iron supplementation significantly improves the response to erythropoiesis-stimulating agent (ESA)-based therapies in patients with cancer-…”
Get more information

Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09) by Matter‐Walstra, K.W., Achermann, R., Rapold, R., Klingbiel, D., Bordoni, A., Dehler, S., Konzelmann, I., Mousavi, M., Clough‐Gorr, K.M., Szucs, T., Schwenkglenks, M., Pestalozzi, B.C.

“…Number of days spent in acute hospitals (DAH) at the end of life is regarded as an important care quality indicator for cancer patients. We analysed DAH during…”
Get full text